By Sheri Kasprzak
New York, Dec. 20 - Lipid Sciences, Inc. wrapped a private placement of its stock for $6.2 million.
The company issued 4,592,591 shares at $1.35 each to a group of institutional investors led by RA Capital Management.
Oppenheimer & Co. was the placement agent.
Proceeds will be used for the company's high-density lipoprotein therapy platform.
Based in Pleasanton, Calif., Lipid Sciences develops treatments for coronary diseases caused by HDL cholesterol.
| Issuer: | Lipid Sciences, Inc.
|
| Issue: | Stock
|
| Amount: | $6.2 million
|
| Shares: | 4,592,591
|
| Price: | $1.35
|
| Warrants: | No
|
| Investors: | RA Capital Management (lead)
|
| Placement agent: | Oppenheimer & Co.
|
| Settlement date: | Dec. 18
|
| Stock symbol: | Nasdaq: LIPD
|
| Stock price: | $1.77 at close Dec. 18
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
